Showing results (1-10 of 228) with videos related to
Sort By:
Pageof 23
Cancers|July 25, 2019
Functional Toll-Like Receptors (TLRs) Are Expressed by a Majority of Primary Human Acute Myeloid Leukemia Cells and Inducibility of the TLR Signaling Pathway Is Associated with a More Favorable PhenotypeAnnette K Brenner, Øystein BruserudNeoplasia (New York, N.Y.)|October 27, 2018
S100 Proteins in Acute Myeloid LeukemiaAnnette K Brenner, Øystein BruserudJournal of Cancer Research and Clinical Oncology|June 21, 2017
The constitutive protease release by primary human acute myeloid leukemia cellsMaria Honnemyr, Øystein Bruserud, Annette K BrennerFrontiers in Immunology|June 3, 2016
A Subset of Patients with Acute Myeloid Leukemia Has Leukemia Cells Characterized by Chemokine Responsiveness and Altered Expression of Transcriptional as well as Angiogenic RegulatorsAnnette K Brenner, Håkon Reikvam, Øystein BruserudFrontiers in Immunology|February 25, 2017
Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular MechanismsAnnette K Brenner, Ina Nepstad, Øystein BruserudMolecules (Basel, Switzerland)|November 16, 2016
The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent CellsAnnette K Brenner, Tor Henrik Andersson Tvedt, Øystein BruserudMolecules (Basel, Switzerland)|November 15, 2014
Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoformsAnnette K Brenner, Håkon Reikvam, Antonio Lavecchia, et al.BMC Pharmacology & Toxicology|May 3, 2015
Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acidElisabeth Ersvaer, Annette K Brenner, Kristin Vetås, et al.Expert Opinion on Therapeutic Targets|June 25, 2014
Heat shock protein 70 - the next chaperone to target in the treatment of human acute myelogenous leukemia?Håkon Reikvam, Annette K Brenner, Ina Nepstad, et al.International Journal of Molecular Sciences|January 19, 2018
The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid LeukemiaSilje Johansen, Annette K Brenner, Sushma Bartaula-Brevik, et al.Pageof 23